155 related articles for article (PubMed ID: 30245963)
1. Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention.
Basnet R; Gong GQ; Li C; Wang MW
Acta Pharm Sin B; 2018 Sep; 8(5):767-771. PubMed ID: 30245963
[TBL] [Abstract][Full Text] [Related]
2. Serum and glucocorticoid-regulated protein kinases: variations on a theme.
Tessier M; Woodgett JR
J Cell Biochem; 2006 Aug; 98(6):1391-407. PubMed ID: 16619268
[TBL] [Abstract][Full Text] [Related]
3. Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3.
Tessier M; Woodgett JR
J Biol Chem; 2006 Aug; 281(33):23978-89. PubMed ID: 16790420
[TBL] [Abstract][Full Text] [Related]
4. Second AKT: the rise of SGK in cancer signalling.
Bruhn MA; Pearson RB; Hannan RD; Sheppard KE
Growth Factors; 2010 Dec; 28(6):394-408. PubMed ID: 20919962
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
[TBL] [Abstract][Full Text] [Related]
6. Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast.
Casamayor A; Torrance PD; Kobayashi T; Thorner J; Alessi DR
Curr Biol; 1999 Feb; 9(4):186-97. PubMed ID: 10074427
[TBL] [Abstract][Full Text] [Related]
7. Phosphoproteomics reveals that the hVPS34 regulated SGK3 kinase specifically phosphorylates endosomal proteins including Syntaxin-7, Syntaxin-12, RFIP4 and WDR44.
Malik N; Nirujogi RS; Peltier J; Macartney T; Wightman M; Prescott AR; Gourlay R; Trost M; Alessi DR; Karapetsas A
Biochem J; 2019 Oct; 476(20):3081-3107. PubMed ID: 31665227
[TBL] [Abstract][Full Text] [Related]
8. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
9. AKT-independent PI3-K signaling in cancer - emerging role for SGK3.
Bruhn MA; Pearson RB; Hannan RD; Sheppard KE
Cancer Manag Res; 2013; 5():281-92. PubMed ID: 24009430
[TBL] [Abstract][Full Text] [Related]
10. SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).
Hou M; Lai Y; He S; He W; Shen H; Ke Z
Oncol Lett; 2015 Jul; 10(1):23-26. PubMed ID: 26170971
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides.
Xu J; Liu D; Gill G; Songyang Z
J Cell Biol; 2001 Aug; 154(4):699-705. PubMed ID: 11514587
[TBL] [Abstract][Full Text] [Related]
12. Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell lines.
Hausmann S; Brandt E; Köchel C; Einsele H; Bargou RC; Seggewiss-Bernhardt R; Stühmer T
PLoS One; 2015; 10(4):e0122689. PubMed ID: 25837824
[TBL] [Abstract][Full Text] [Related]
13. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway.
Park J; Leong ML; Buse P; Maiyar AC; Firestone GL; Hemmings BA
EMBO J; 1999 Jun; 18(11):3024-33. PubMed ID: 10357815
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase.
Kobayashi T; Deak M; Morrice N; Cohen P
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):189-97. PubMed ID: 10548550
[TBL] [Abstract][Full Text] [Related]
15. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms.
Lang F; Böhmer C; Palmada M; Seebohm G; Strutz-Seebohm N; Vallon V
Physiol Rev; 2006 Oct; 86(4):1151-78. PubMed ID: 17015487
[TBL] [Abstract][Full Text] [Related]
16. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.
Kobayashi T; Cohen P
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):319-28. PubMed ID: 10191262
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Akt-related cytokine-independent survival kinase requires interaction of its phox domain with endosomal phosphatidylinositol 3-phosphate.
Virbasius JV; Song X; Pomerleau DP; Zhan Y; Zhou GW; Czech MP
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12908-13. PubMed ID: 11606732
[TBL] [Abstract][Full Text] [Related]
18. Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.
Gong GQ; Wang K; Dai XC; Zhou Y; Basnet R; Chen Y; Yang DH; Lee WJ; Buchanan CM; Flanagan JU; Shepherd PR; Chen Y; Wang MW
Acta Pharmacol Sin; 2018 Dec; 39(12):1902-1912. PubMed ID: 30038340
[TBL] [Abstract][Full Text] [Related]
19. Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.
Jiang F; Liu H; Peng F; Liu Z; Ding K; Song J; Li L; Chen J; Shao Q; Yan S; De Veirman K; Vanderkerken K; Fu R
Cancer Biol Med; 2021 May; 18(3):721-33. PubMed ID: 33960177
[TBL] [Abstract][Full Text] [Related]
20. WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant.
Li T; Wang J; Wang X; Yang N; Chen SM; Tong LJ; Yang CH; Meng LH; Ding J
J Pharmacol Exp Ther; 2010 Sep; 334(3):830-8. PubMed ID: 20522531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
